BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7283551)

  • 1. A comparison of the vasoconstrictor effects of angiotensin II and angiotensin III in the canine renal vasculature.
    Satoh S; Itsukaichi O; Ohyama Y; Hayashi M
    Arch Int Pharmacodyn Ther; 1981 Jun; 251(2):301-9. PubMed ID: 7283551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrarenal vascular effects of angiotensin II and angiotensin III in the dog.
    Britton SL; Fiksen-Olsen MJ; Houck PC; Romero JC
    J Hypertens; 1983 Jun; 1(1):95-101. PubMed ID: 6681031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of des-aspartate-angiotensin I on the actions of angiotensin III in the renal and mesenteric vasculature of normo- and hypertensive rats.
    Mustafa MR; Dharmani M; Kunheen NK; Sim MK
    Regul Pept; 2004 Aug; 120(1-3):15-22. PubMed ID: 15177916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of angiotensins II and III as vasoconstrictors in the hepatic and hindlimb vasculatures of dogs.
    Britton SL; Ronau TF; Metting PJ
    Proc Soc Exp Biol Med; 1986 Jan; 181(1):125-30. PubMed ID: 3945615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation by arachidonic acid of the effect of vasoconstrictor stimuli in the canine kidney.
    Susić H; Malik KU
    J Pharmacol Exp Ther; 1981 Nov; 219(2):377-82. PubMed ID: 6793715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin.
    Aiken JW; Vane JR
    J Pharmacol Exp Ther; 1973 Mar; 184(3):678-87. PubMed ID: 4347050
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin antagonists with increased specificity for the renal vasculature.
    Taub KJ; Caldicott WJ; Hollenberg NK
    J Clin Invest; 1977 Mar; 59(3):528-35. PubMed ID: 190270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of altered sodium balance upon renal vascular reactivity to angiotensin II and norepinephrine in the dog. Mechanism of variation in angiotensin responses.
    Oliver JA; Cannon PJ
    J Clin Invest; 1978 Mar; 61(3):610-23. PubMed ID: 641142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Des-Asp1] angiotensin II: mediator of the renin-angiotensin system?
    Freeman RH; Davis JO; Lohmeier TE; Spielman WS
    Fed Proc; 1977 Apr; 36(5):1766-70. PubMed ID: 321257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of renal nerve stimulation, norepinephrine and angiotensin II on renal blood flow in relation to release of PG-like substances in anesthetized dogs.
    Satoh S; Ohyama Y; Hayashi M
    Arch Int Pharmacodyn Ther; 1981 Dec; 254(2):304-16. PubMed ID: 7337502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escape from the sodium-retaining action of intrarenal angiotensins II and III in the conscious dog.
    Dickstein GM; Woodson JF; Lamb NE; Rose CE; Peach MJ; Carey RM
    Endocrinology; 1985 Nov; 117(5):2160-9. PubMed ID: 4042980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of angiotensin III from [des-Asp1]angiotensin I in the mesentric vasculature.
    Sexton JM; Britton SL; Beierwaltes WH; Fiksen-Olsen MJ; Romero JC
    Am J Physiol; 1979 Aug; 237(2):H218-23. PubMed ID: 464116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by bradykinin of the vascular action of angiotensin II in the dog kidney.
    Susić H; Nasjletti A; Malik KU
    J Pharmacol Exp Ther; 1981 Jul; 218(1):103-7. PubMed ID: 6165819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of angiotensin II and angiotensin III as vasoconstrictors in the mesenteric circulation of dogs.
    Britton SL; Sexton JM; Fiksen-Olsen MJ; Werness PG; Romero JC
    Circ Res; 1980 Jan; 46(1):146-51. PubMed ID: 7349914
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of captopril-induced renal vasodilatation in anesthetized dogs after nonhypotensive hemorrhage.
    Wong PC; Zimmerman BG
    J Pharmacol Exp Ther; 1980 Oct; 215(1):104-9. PubMed ID: 7005423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific desensitization of the canine renal vasculature to angiotensin II despite cyclo-oxygenase inhibition.
    Meggs LG; Katzberg RW; DeLeeuw P; Hollenberg NK
    Yale J Biol Med; 1985; 58(5):453-8. PubMed ID: 3937341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the renin-angiotensin system on the effect of prostaglandin synthesis inhibitors in the renal vasculature.
    Satoh S; Zimmerman BG
    Circ Res; 1975 Jun; 36(6 Suppl 1):89-96. PubMed ID: 805674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological evaluation in conscious dogs of factors involved in the renal vasodilator effect of captopril.
    Wong PC; Zimmerman BG; Kraft E; Kounenis G; Friedman P
    J Pharmacol Exp Ther; 1981 Dec; 219(3):646-50. PubMed ID: 7028950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphasic actions of angiotensin IV on renal blood flow in the rat.
    Handa RK
    Regul Pept; 2006 Sep; 136(1-3):23-9. PubMed ID: 16780972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of adenosine compounds of the vascular bed and effects of dilazep, theophylline, and indomethacin on blood flow changes of the postocclusive renal vessels].
    Ohtaki Y; Nakanishi H; Ueda J
    Nihon Yakurigaku Zasshi; 1977 Jan; 73(1):93-102. PubMed ID: 558949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.